Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

This package is available to First Home Buyers only through our First Home Buyer Program. We will arrange the loan for you. To qualify for our First Home Buyer Program conditions of course apply ...

This package is available to First Home Buyers only through our First Home Buyer Program. We will arrange the loan for you. To qualify for our First Home Buyer Program conditions of course apply ...

Hover over Tap a data point to see when it was last updated. Median values are calculated based on data over a 12 month period. Data is provided by CoreLogic. CoreLogic is a leading provider of ...